The Relationship Between Visceral Adiposity Index and Epicardial Adipose Tissue in Patients with Type 2 Diabetes Mellitus

dc.contributor.authorBaloglu, Ismail
dc.contributor.authorTurkmen, Kultigin
dc.contributor.authorSelcuk, Nedim Yilmaz
dc.contributor.authorTonbul, Halil Zeki
dc.contributor.authorOzcicek, Adalet
dc.contributor.authorHamur, Hikmet
dc.contributor.authorIyisoy, Sinan
dc.date.accessioned2024-02-23T14:16:49Z
dc.date.available2024-02-23T14:16:49Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractIntroduction and aim Cardiovascular diseases remain the most common cause of morbidity and mortality in patients with diabetes. Epicardial adipose tissue (EAT), visceral fat depot of the heart, was found to be associated with coronary artery disease in cardiac and non-cardiac patients. Increased visceral adiposity is associated with proinflammatory activity, impaired insulin sensitivity, increased risk of atherosclerosis and high mortality. In the present study we aimed to investigate the relationship between EAT and visceral adiposity index (VAI) in patients with diabetes. Methods This was a cross-sectional study involving 128 patients with type 2 diabetes mellitus (73 females, 55 males; mean age, 54.09++9.17 years) and 32 control subjects (23 females, 9 males; mean age, 50.09++7.81 years). EAT was measured by using a trans-thoracic echocardiograph. Parameters such as waist circumference (WC), body mass index (BMI), triglyceride and high density lipoprotein (HDL) cholesterol were used to calculate VAI. Result EAT and VAI measurements were significantly higher in patients with diabetes when compared to control subjects. In the bivariate correlation analysis, VAI was positively correlated with uric acid level (r=0.214, p=0.015), white blood cell count (r=0.262, p=0.003), platelet count (r=0.223, p=0.011) and total cholesterol levels (r=0.363, p<0.001). Also, VAI was found to be the independent predictor of EAT. Conclusion Simple calculation of VAI was found to be associated with increased EAT in patients with type 2 diabetes.en_US
dc.identifier.doi10.1055/a-0892-4290
dc.identifier.endpage395en_US
dc.identifier.issn0947-7349
dc.identifier.issn1439-3646
dc.identifier.issue5en_US
dc.identifier.pmid31060096en_US
dc.identifier.scopus2-s2.0-85105430824en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage390en_US
dc.identifier.urihttps://doi.org/10.1055/a-0892-4290
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12823
dc.identifier.volume129en_US
dc.identifier.wosWOS:000647220800008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag Kgen_US
dc.relation.ispartofExperimental And Clinical Endocrinology & Diabetesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEpicardial Adipose Tissueen_US
dc.subjectVisceral Adiposity Indexen_US
dc.subjectDiabetes Mellitusen_US
dc.titleThe Relationship Between Visceral Adiposity Index and Epicardial Adipose Tissue in Patients with Type 2 Diabetes Mellitusen_US
dc.typeArticleen_US

Dosyalar